Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Phenylephrine

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Phenylephrine

EINECS 200-424-8
CAS No. 59-42-7 Density 1.159 g/cm3
Solubility Melting Point 171°C
Formula C9H13NO2 Boiling Point 341.1 °C at 760 mmHg
Molecular Weight 167.23 Flash Point 163.4 °C
Transport Information Appearance
Safety 26-36-45 Risk Codes 22-36/37/38
Molecular Structure Molecular Structure of 59-42-7 (Benzenemethanol,3-hydroxy-a-[(methylamino)methyl]-, (aR)-) Hazard Symbols
Synonyms

m-Methylaminoethanolphenol;m-Oxedrine;m-Sympathol;Benzenemethanol,3-hydroxy-a-[(methylamino)methyl]-, (R)-;Benzyl alcohol, m-hydroxy-a-[(methylamino)methyl]-, (-)- (7CI,8CI);(-)-Phenylephrine;(-)-m-Hydroxy-a-(methylaminomethyl)benzylalcohol;(-)-m-Oxedrine;(-)-m-Synephrine;(R)-(-)-Phenylephrine;(R)-Phenylephrine;L-Phenylephedrine;Mesaton;Mesatone;Metaoxedrin;Metaoxedrine;Metasympatol;Metasynephrine;Mezaton;Neo-Synephrine;Phenylephrine;R(-)-Mezaton;Visadron;l-m-Hydroxy-a-[(methylamino)methyl]benzylalcohol;m-Sympatol;m-Synephrine;

 

Phenylephrine Consensus Reports

 Phenylephrine (59-42-7) is reported in EPA TSCA Inventory.

Phenylephrine Specification

Phenylephrine with the CAS NO. 59-42-7 has the Synonyms of (-)-Phenylephrine;phenylephrine base; (-)-M-hydroxy-alpha-(methylaminomethyl)benzyl alcohol; (-)-M-hydroxy-alpha-(methylaminomethyl)benzylalcohol; (-)-M-oxedrine; (R)-3-hydroxy-alpha-[(methylamino)methyl]benzenemethanol hydrochloride; (R)-benzenemethano;(r)-phenylephrine. Phenylephrine is a selective α1-adrenergic receptor agonist used primarily as a decongestant, as an agent to dilate the pupil, and to increase blood pressure.

Physical properties about Phenylephrine are: (1)ACD/LogP: 0.117; (2)ACD/LogD (pH 5.5): -2.91; (3)ACD/LogD (pH 7.4): -1.78; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 1.00; (7)ACD/KOC (pH 7.4): 1.00; (8)#H bond acceptors: 3; (9)#H bond donors: 3; (10)#Freely Rotating Bonds: 5; (11)Index of Refraction: 1.572; (12)Molar Refractivity: 47.449 cm3; (13)Molar Volume: 144.258 cm3; (14)Polarizability: 18.81 10-24cm3; (15)Surface Tension: 49.1800003051758 dyne/cm; (16)Density: 1.159 g/cm3; (17)Flash Point: 163.4 °C; (18)Enthalpy of Vaporization: 61.709 kJ/mol; (19)Boiling Point: 341.068 °C at 760 mmHg

Uses of Phenylephrine: Phenylephrine is used as a decongestant sold as an oral medicine, as a nasal spray, or as eye drops. Phenylephrine is now the most common over-the-counter (OTC) decongestant in the United States. Phenylephrine is sometimes used as a vasopressor to increase the blood pressure in unstable patients with hypotension. It is used as an eye drop to dilate the pupil in order to facilitate visualization of the retina. It is often used in combination with tropicamide. Narrow-angle glaucoma is a contraindication to phenylephrine use.

When you are using this chemical, please be cautious about it as the following:
1. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice;
2. Wear suitable protective clothing;
3. In case of accident or if you feel unwell, seek medical advice immediately (show label where possible);

You can still convert the following datas into molecular structure:
(1)InChI=1S/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1;
(2)InChIKey=SONNWYBIRXJNDC-VIFPVBQESA-N;
(3)Smilesc1([C@H](CNC)O)cc(ccc1)O;

 The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
infant TDLo ocular 5500ug/kg (5.5mg/kg) VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION Anesthesiology. Vol. 36, Pg. 187, 1972.
 
mouse LD50 intravenous 38mg/kg (38mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

SKIN AND APPENDAGES (SKIN): HAIR: OTHER

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP
Acta Pharmacologica et Toxicologica. Vol. 38, Pg. 474, 1976.
 
mouse LD50 subcutaneous 875mg/kg (875mg/kg)   Farmakologiya i Toksikologiya Vol. 28, Pg. 46, 1965.
 
mouse LDLo intraperitoneal 60mg/kg (60mg/kg) CARDIAC: OTHER CHANGES Journal of Pharmacology and Experimental Therapeutics. Vol. 160, Pg. 22, 1968.
 
rat LD50 intraduodenal 65mg/kg (65mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 180, Pg. 155, 1969.
 
rat LD50 oral 350mg/kg (350mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 180, Pg. 155, 1969.
 
rat LD50 subcutaneous 28mg/kg (28mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 85, Pg. 119, 1945.
women TDLo ocular 188ug/kg (.188mg/kg) VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION Anesthesiology. Vol. 36, Pg. 187, 1972.
 

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields